Report Detail
Global (United States, European Union and China) Emergency Contraceptives Market Research Report 2019-2025
- RnM3401294 |
- 09 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Emergency Contraceptives is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Emergency Contraceptives.
This report studies the global market size of Emergency Contraceptives, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Emergency Contraceptives sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
...
Market Segment by Product Type
Combined estrogen and progestin pills
Progestin-only (as Levonorgestrel) pills
Antiprogestin (as mifepristone) pills
Ulipristal acetate pills
Market Segment by Application
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Emergency Contraceptives status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Emergency Contraceptives manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Emergency Contraceptives are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Emergency Contraceptives Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Combined estrogen and progestin pills
- 1.3.3 Progestin-only (as Levonorgestrel) pills
- 1.3.4 Antiprogestin (as mifepristone) pills
- 1.3.5 Ulipristal acetate pills
- 1.4 Market Segment by Application
- 1.4.1 Global Emergency Contraceptives Market Share by Application (2019-2025)
- 1.4.2 Hospital pharmacies
- 1.4.3 Retail pharmacies
- 1.4.4 Online pharmacies
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Emergency Contraceptives Market Size
- 2.1.1 Global Emergency Contraceptives Revenue 2014-2025
- 2.1.2 Global Emergency Contraceptives Sales 2014-2025
- 2.2 Emergency Contraceptives Growth Rate by Regions
- 2.2.1 Global Emergency Contraceptives Sales by Regions 2014-2019
- 2.2.2 Global Emergency Contraceptives Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Emergency Contraceptives Sales by Manufacturers
- 3.1.1 Emergency Contraceptives Sales by Manufacturers 2014-2019
- 3.1.2 Emergency Contraceptives Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Emergency Contraceptives Revenue by Manufacturers (2014-2019)
- 3.2.2 Emergency Contraceptives Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Emergency Contraceptives Market Concentration Ratio (CR5 and HHI)
- 3.3 Emergency Contraceptives Price by Manufacturers
- 3.4 Key Manufacturers Emergency Contraceptives Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Emergency Contraceptives Market
- 3.6 Key Manufacturers Emergency Contraceptives Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Combined estrogen and progestin pills Sales and Revenue (2014-2019)
- 4.1.2 Progestin-only (as Levonorgestrel) pills Sales and Revenue (2014-2019)
- 4.1.3 Antiprogestin (as mifepristone) pills Sales and Revenue (2014-2019)
- 4.1.4 Ulipristal acetate pills Sales and Revenue (2014-2019)
- 4.2 Global Emergency Contraceptives Sales Market Share by Type
- 4.3 Global Emergency Contraceptives Revenue Market Share by Type
- 4.4 Emergency Contraceptives Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Emergency Contraceptives Sales by Application
6 United States
- 6.1 United States Emergency Contraceptives Breakdown Data by Company
- 6.2 United States Emergency Contraceptives Breakdown Data by Type
- 6.3 United States Emergency Contraceptives Breakdown Data by Application
7 European Union
- 7.1 European Union Emergency Contraceptives Breakdown Data by Company
- 7.2 European Union Emergency Contraceptives Breakdown Data by Type
- 7.3 European Union Emergency Contraceptives Breakdown Data by Application
8 China
- 8.1 China Emergency Contraceptives Breakdown Data by Company
- 8.2 China Emergency Contraceptives Breakdown Data by Type
- 8.3 China Emergency Contraceptives Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Emergency Contraceptives Breakdown Data by Company
- 9.2 Rest of World Emergency Contraceptives Breakdown Data by Type
- 9.3 Rest of World Emergency Contraceptives Breakdown Data by Application
- 9.4 Rest of World Emergency Contraceptives Breakdown Data by Countries
- 9.4.1 Rest of World Emergency Contraceptives Sales by Countries
- 9.4.2 Rest of World Emergency Contraceptives Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Genetics
- 10.1.1 Genetics Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Emergency Contraceptives
- 10.1.4 Emergency Contraceptives Product Introduction
- 10.1.5 Genetics Recent Development
- 10.2 Teva Pharmaceutical
- 10.2.1 Teva Pharmaceutical Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Emergency Contraceptives
- 10.2.4 Emergency Contraceptives Product Introduction
- 10.2.5 Teva Pharmaceutical Recent Development
- 10.3 Uniprix
- 10.3.1 Uniprix Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Emergency Contraceptives
- 10.3.4 Emergency Contraceptives Product Introduction
- 10.3.5 Uniprix Recent Development
- 10.4 Gavis Pharmaceuticals
- 10.4.1 Gavis Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Emergency Contraceptives
- 10.4.4 Emergency Contraceptives Product Introduction
- 10.4.5 Gavis Pharmaceuticals Recent Development
- 10.5 HRA Pharma
- 10.5.1 HRA Pharma Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Emergency Contraceptives
- 10.5.4 Emergency Contraceptives Product Introduction
- 10.5.5 HRA Pharma Recent Development
- 10.6 Mankind Pharma
- 10.6.1 Mankind Pharma Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Emergency Contraceptives
- 10.6.4 Emergency Contraceptives Product Introduction
- 10.6.5 Mankind Pharma Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Emergency Contraceptives Sales Channels
- 11.2.2 Emergency Contraceptives Distributors
- 11.3 Emergency Contraceptives Customers
12 Market Forecast
- 12.1 Global Emergency Contraceptives Sales and Revenue Forecast 2019-2025
- 12.2 Global Emergency Contraceptives Sales Forecast by Type
- 12.3 Global Emergency Contraceptives Sales Forecast by Application
- 12.4 Emergency Contraceptives Forecast by Regions
- 12.4.1 Global Emergency Contraceptives Sales Forecast by Regions 2019-2025
- 12.4.2 Global Emergency Contraceptives Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Emergency Contraceptives. Industry analysis & Market Report on Emergency Contraceptives is a syndicated market report, published as Global (United States, European Union and China) Emergency Contraceptives Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Emergency Contraceptives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
